ENTUK
Improve patient care & promote understanding of conditions of the ear, nose, throat, head & neck Provide information to the public & media Encourage & support research & provide continuing education for specialists Encourage recruitment into the specialty Promote high standards in specialist trainingRepresent the specialty at the Royal Colleges of Surgeons and to government bodies.
Financial health, per its FY2025 accounts
The accounts state that the Group remains in a strong and stable financial position with unrestricted reserves of £3.89 million and cash balances of £1.26 million. Although the Group recorded a net operating deficit of £24,328 before investment gains, the overall net surplus was £106,878 due to a revaluation gain on investments. The Trustees consider current reserve levels appropriate to manage financial risks and support ongoing commitments.
What the accounts disclose
“Reserves are set with reference to a defined period of core operating expenditure, expressed as approximately twelve months of cover.” — page 29
“The trading subsidiary, ENTUK Enterprises Ltd, delivers the annual calendar of events including the BACO conference.” — page 26
Funders the charity credits
- Olympus
- Medtronic
- Ambu
- Mylan UK Healthcare
Structured financials (annual return, FY ending 30/09/2025)
Register events
- Received assets from another charity (06/01/2023)
Trustees
- TARANJIT SINGH TATLAchair
- Elaine Hanley
- Helen Cocks
- Janet Marianne Legget-Jones
- PROFESSOR NIRMAL KUMAR
- Paramita Baruah
- Professor Nigel Peter Weatherill
- Professor Vinidh Paleri
- RAM P MOORTHY
- Sean Carrie
- Todd Kanzara
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £971k | £995k |
| 30/09/2024 | £939k | £860k |
| 30/09/2023 | £1.7m | £1.4m |
| 30/09/2022 | £729k | £705k |
| 30/09/2021 | £1.0m | £798k |
Common questions
Is ENTUK financially healthy?
Per its FY2025 accounts: The accounts state that the Group remains in a strong and stable financial position with unrestricted reserves of £3.89 million and cash balances of £1.26 million. Although the Group recorded a net operating deficit of £24,328 before investment gains, the overall net surplus was £106,878 due to a revaluation gain on investments. The Trustees consider current reserve levels appropriate to manage financial risks and support ongoing commitments. Its FY2025 accounts were audited by Edmund Carr LLP.